David Burrows
About David Burrows
David Burrows is a Director of CMC at KalVista Pharmaceuticals, Inc., with a background in analytical development spanning over two decades at Patheon. He holds a Bachelor of Science in Chemistry from the University of Leeds.
Current Role at KalVista Pharmaceuticals
David Burrows serves as the Director of CMC at KalVista Pharmaceuticals, Inc. since 2022. In this role, he oversees the Chemistry, Manufacturing, and Controls (CMC) aspects of the company's operations. His responsibilities include ensuring compliance with regulatory requirements and managing the development of pharmaceutical products. He is based in the Greater Salisbury Area.
Previous Experience at KalVista Pharmaceuticals
Before his current position, David Burrows worked as the Associate Director at KalVista Pharmaceuticals, Inc. from 2020 to 2022. During this time, he contributed to the development and implementation of CMC strategies, focusing on the early phases of product development. His experience in this role laid the groundwork for his advancement to Director.
Career at Patheon
David Burrows spent 20 years at Patheon, where he held multiple positions. He served as the Analytical Development Manager for Early Phase Clinical Trial Materials from 2000 to 2020. Additionally, he was the Associate Director of Analytical Development during his tenure. His work at Patheon involved overseeing analytical processes and ensuring the quality of pharmaceutical products.
Educational Background
David Burrows studied at the University of Leeds, where he earned a Bachelor of Science (BSc) in Chemistry from 1990 to 1993. Prior to that, he attended William Hulme's Grammar School from 1981 to 1988. His educational background in chemistry has provided a strong foundation for his career in the pharmaceutical industry.